Fidelity Investments’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.67M | Buy |
|
|||||
|
2025
Q2 | $63.6K | Sell |
|
|||||
|
2025
Q1 | $191K | Buy |
|
|||||
|
2024
Q4 | $169K | Sell |
|
|||||
|
2024
Q3 | $778K | Buy |
|
|||||
|
2024
Q2 | $180K | Buy |
|
|||||
|
2024
Q1 | $306K | Buy |
|
|||||
|
2023
Q4 | $297K | Buy |
|
|||||
|
2023
Q3 | $219K | Buy |
|
|||||
|
2023
Q2 | $259K | Sell |
|
|||||
|
2023
Q1 | $3.74M | Sell |
|
|||||
|
2022
Q4 | $13.3M | Sell |
|
|||||
|
2022
Q3 | $18.3M | Sell |
|
|||||
|
2022
Q2 | $27.3M | Sell |
|
|||||
|
2022
Q1 | $72.3M | Sell |
|
|||||
|
2021
Q4 | $65.1M | Sell |
|
|||||
|
2021
Q3 | $92.7M | Buy |
|
|||||
|
2021
Q2 | $111M | Buy |
|
|||||
|
2021
Q1 | $87.2M | Buy |
|
|||||
|
2020
Q4 | $73.2M | Sell |
|
|||||
|
2020
Q3 | $50.9M | Sell |
|
|||||
|
2020
Q2 | $39.3M | Sell |
|
|||||
|
2020
Q1 | $34.4M | Sell |
|
|||||
|
2019
Q4 | $48.9M | Sell |
|
|||||
|
2019
Q3 | $43.6M | Sell |
|
|||||
|
2019
Q2 | $65.5M | Buy |
|
|||||
|
2019
Q1 | $64.4M | Buy |
|
|||||
|
2018
Q4 | $57.5M | Buy |
|
|||||
|
2018
Q3 | $80.1M | Buy |
|
|||||
|
2018
Q2 | $69.4M | Buy |
|
|||||
|
2018
Q1 | $78.2M | Buy |
|
|||||
|
2017
Q4 | $85.3M | Buy |
|
|||||
|
2017
Q3 | $47.4M | Buy |
|
|||||
|
2017
Q2 | $50.1M | Buy |
|
|||||
|
2017
Q1 | $60.7M | Buy |
|
|||||
|
2016
Q4 | $35.3M | Buy |
|
|||||
|
2016
Q3 | $52M | Buy |
|
|||||
|
2016
Q2 | $30.8M | Buy |
|
|||||
|
2016
Q1 | $28.3M | Buy |
|
|||||
|
2015
Q4 | $40.2M | Buy |
|
|||||
|
2015
Q3 | $32.8M | Buy |
|
|||||
|
2015
Q2 | $42.4M | Buy |
|
|||||
|
2015
Q1 | $47.1M | Buy |
|
|||||
|
2014
Q4 | $29.9M | Hold |
|
|||||
|
2014
Q3 | $25.5M | Buy |
|
|||||
|
2014
Q2 | $47.7M | Buy |
|
|||||
|
2014
Q1 | $50.9M | Buy |
|
|||||
|
2013
Q4 | $25.4M | Sell |
|
|||||
|
2013
Q3 | $37.8M | Hold |
|
|||||
|
2013
Q2 | $35.3M | Buy |
|